Author

Charles E Leonard

University of Pennsylvania, Perelman School of Medicine - Cited by 3,253 - Pharmacoepidemiology

Biography

Dr. Charles E Leonard is from Center for Pharmacoepidemiology Research and Training, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania,  located in USA. His study is about Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States. He is also specialized in Clinical Epidemiologyand Biostatistics, Pharmacoepidemiology Research and Training.
Title
Cited by
Year
Risk for recurrent venous thromboembolism and bleeding with apixaban compared with rivaroxaban: an analysis of real-world data
GK Dawwas, CE Leonard, JD Lewis, A CukerAnnals of internal medicine 175 (1), 20-28, 2022202
25
2022
Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with valvular atrial fibrillation: a population-based cohort study
GK Dawwas, E Dietrich, A Cuker, GD Barnes, CE Leonard, JD LewisAnnals of internal medicine 174 (7), 910-919, 2021202
23
2021
Preoperative sedative-hypnotic medication use and adverse postoperative outcomes
TG Gaulton, H Wunsch, LJ Gaskins, CE Leonard, S Hennessy, M Ashburn, ...Annals of surgery 274 (2), e108, 2021202
19
2021
Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies
V Lo Re III, DM Carbonari, J Jacob, WR Short, CE Leonard, JG Lyons, ...Pharmacoepidemiology and Drug Safety 30 (), 899-909, 2021202
7
2021
National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016
KE Evoy, L Roccograndi, S Le, CE Leonard, JR Covvey, L Ochs, ...Journal of Substance Abuse Treatment 119, 108141, 2020202
5
2020
Population‐based signals of antidepressant drug interactions associated with unintentional traumatic injury
CE Leonard, CM Brensinger, EK Acton, TA Miano, GK Dawwas, JR Horn, ...Clinical Pharmacology & Therapeutics 110 (2), 409-423, 2021202
5
2021
Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis
TP Pham Nguyen, CE Leonard, SJ Bird, AW Willis, AG HamedaniMuscle & Nerve 64 (2), 16-162, 2021202
5
2021
The hepatitis C care cascade during the direct-acting antiviral era in a United States commercially insured population
ND Ferrante, CW Newcomb, KA Forde, CE Leonard, J Torgersen, ...Open forum infectious diseases 9 (9), ofac44, 2022202
5
2022
Research and scholarly methods: propensity scores
D Medaglio, AJ Stephens‐Shields, CE LeonardJournal of the American College of Clinical Pharmacy 5 (), 67-75, 2022202
4
2022
Angiotensin‐converting enzyme inhibitors used concomitantly with insulin secretagogues and the risk of serious hypoglycemia
Y Hee Nam, CM Brensinger, WB Bilker, JH Flory, CE Leonard, ...Clinical Pharmacology & Therapeutics 111 (1), 218-226, 2022202
4
2022
Skeletal muscle relaxant drug–drug–drug interactions and unintentional traumatic injury: Screening to detect three‐way drug interaction signals
C Chen, S Hennessy, CM Brensinger, GK Dawwas, EK Acton, WB Bilker, ...British Journal of Clinical Pharmacology 88 (11), 773-783, 2022202
4
2022
Opioid drug-drug-drug interactions and unintentional traumatic injury: screening to detect three-way drug interaction signals
EK Acton, S Hennessy, CM Brensinger, WB Bilker, TA Miano, S Dublin, ...Frontiers in pharmacology 1, 845485, 2022202
3
2022
3
2022
Signals of muscle relaxant drug interactions associated with unintentional traumatic injury: a population-based screening study
GK Dawwas, S Hennessy, CM Brensinger, EK Acton, WB Bilker, S Chung, ...CNS drugs 36 (4), 389-400, 0
2
2022
Rate of major bleeding with ibrutinib versus bendamustine‐rituximab in chronic lymphocytic leukemia: A population‐based cohort study
N Dhopeshwarkar, W Yang, S Hennessy, JM Rhodes, A Cuker, ...American Journal of Hematology 97 (9), E33-E335, 0
2
2022
Evaluation of serious bleeding signals during concomitant use of clopidogrel and hypnotic drugs
TPP Nguyen, CM Brensinger, WB Bilker, S Hennessy, CE LeonardBiomedicine & Pharmacotherapy 139, 111559, 010
2
2021
Knowledge of biosimilars and perceptions of the naming conventions for biosimilar products in clinical practice in the United States
M Olave, C Lavery, CE Leonard, VL Re III, JA Shea, J Kay, JF BakerDrugs & Therapy Perspectives 37 (7), 338-346, 010
2
2021
High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism
H Whitworth, HH Clark, RA Hubbard, C Witmer, CE Leonard, L RaffiniJournal of Thrombosis and Haemostasis 2 (), 47-56, 2023202
1
2023